Methods Experimental Preparations
Infarction was produced in male Sprague-Dawley rats (body weight, 250 to 300 g) by left coronary artery ligation as previously described19 using the modification of McLean et al. 20 Sham-operated rats served as controls. With this method, the 24-hour mortality rate was 40% in the infarcted rats. All rats were fed standard rat chow and given water ad libitum. Subsequent experiments were started 7 weeks after surgery. Rats were screened for evidence of large myocardial infarction 7 days after surgery by surface ECG recording. 5 Previous studies have shown that most rats identified in this manner have infarction of >40% of the LV, elevated LV end-diastolic pressure and volume, and impaired systolic function. 5 Five percent of infarcted rats died before randomization at day 7.
Instrumentation
Animals were anesthetized with halothane (1% halothane in oxygen), and catheters (PE 50) were placed in the jugular vein, the tail artery, and via the right carotid artery in the LV as described recently.21 Catheter positions were verified by registration of typical pressure waves with pressure transducers (Statham ID 23 P). After closure, the rats were allowed to recover for at least 3 hours before experimental procedures were initiated. This time has been found to be sufficient to ensure a return to steady-state conditions in the rat. 21 Regional Blood Flow Measurement To determine regional coronary blood flow and cardiac output, radioactive microspheres 15+5 jm in diameter (New England Nuclear, Dreieich, Germany) were used according to the reference sample technique22 as adapted for use in rats. 21 Regional blood flow was measured twice, before and after drug intervention, by injection of two different radioactive microspheres (`41Ce and`03Ru). The first measurement was taken for determination of baseline flow. To assess coronary vascular reserve, a second injection of microspheres was performed under maximal coronary dilation induced by dipyridamole (2 mg * kg body w'l * min-1 over 10 minutes) via the jugular vein.23 As reported by Wangler et al,22 this dose and administration protocol produce maximal coronary dilation in the rat. At the end of the study, animals were anesthetized with ketamine (30 mg/kg) and phenobarbital (30 mg/kg). The heart then was fixed as detailed in the next section. At the end of the fixation procedure, organs and tissue samples were quickly removed, and all samples were immediately blotted, weighed, and transferred to a two-channel gamma-scintillation counter (Packard Minaxi Auto Gamma Counter, Packard Instruments) for determination of radioactivity levels as described by Karam et al.2 Blood flow data concerning the LV were obtained from the noninfarcted part of the LV.2 In sham-operated animals, coronary blood flow was measured in analogous portions of the LV.
Hemodynamics
Tracings from the LV and tail catheters were recorded and used to obtain heart rate, LV peak systolic pressure, LV end-diastolic pressure, and mean arterial pressure. Total vascular resistance was determined from mean arterial pressure and cardiac output data (mL * min`* kg-'). Coronary vascular resistance was calculated by dividing mean arterial pressure recorded just before each microsphere injection by the corresponding coronary blood flow. With the exception of cardiac output, hemodynamic data were collected immediately before the microsphere injection.
Determination of Infarct Size
The LV and septum were separated from the right ventricle (RV) (free wall), weighed, and fixed in 10% formalin. Twentyfour hours later, the LV was cut into three transverse slices from apex to base. Three thin transversal slices of each piece were separated and used for histological examination. Thereafter, the remaining noninfarcted left myocardium was cut and prepared free of scar tissue and border zone. These three noninfarcted pieces of the LV were pooled and counted for radioactivity as described by Karam et 25 Since the objective of the present study was to assess the effects of treatment on LV structure rather than short-term hemodynamic effects of ACE inhibition26 and AT1 receptor blockade, the treatment regimen was discontinued 3 days before experiments started. Regional blood flow and hemodynamics were obtained in infarcted and sham-operated animals 7 weeks after surgery. During the 6-week treatment period, three animals died, two from the placebo group and one from the enalapril group. One additional animal from the losartan group died after instrumentation with an LV catheter.
Fiation Procedure
After hemodynamic parameters were obtained, animals were anesthetized with a combination of ketamine (30 mg/kg) and phenobarbital (30 mg/kg). In rapid succession, the abdomen was opened, the abdominal aorta was cannulated, and the heart was arrested in diastole by injection of KCl (1 mL/0.2 mol) directly into the LV.2 The chest was opened, the right atrium cut, and the coronary artery vasculature perfused with phosphate buffer (0.1 mol/L, pH 7.4) at a pressure equal to the in vivo measured mean arterial pressure. After perfusion with buffer, the coronary circulation was perfused with a solution containing 2% paraformaldehyde and 2.5% glutaraldehyde, pH 7.2.24 After complete fixation, the heart was removed, the atria and great vessels were trimmed away, and the ventricles were separated and weighed. For determination of interstitial fibrosis, medial thickness, perivascular fibrosis, and capillary density, the myocardium of the surviving noninfarcted LV was examined.
Morphology and Morphometry
Three coronal sections were embedded in paraffin and sequentially cut into slices 5 
where VA is vessel luminal area, MA is medial area, and MT is medial thickness. Medial area was defined as the area from the endothelium to the outer limit of the tunica media.33 All tissue sections were scanned systematically, and all arteries were photographed. The smallest diameter of the vessel, which was representative of luminal diameter, was used for determination.32 For each ventricular region, slides from all blocks were analyzed. Care was taken to exclude necrotic areas or areas with artificial separation. The lumens of all arteries were measured from the negatives, which were projected onto a screen to enlarge the images (x 12). The negatives were also checked to verify whether any arteries were photographed more than once. For each section, a minimum of 10 vessels were found to be cut cross sectionally; each was examined.31
To ensure the accuracy of our vessel measurements, the effect of refraction in optical microscopic measurements was taken into account. Therefore, we used the correction formula for quantitative optical microscopic analysis previously reported by Chen et al34 to correct the geometric shape of intramural arteries (ie, circular or elliptical cross-cut sections).
All collagen surrounding an intramyocardial small artery was considered perivascular fibrosis. 31 
Results
Infarct Size and Reactive Hypertrophy The baseline characteristics of sham-operated and infarcted animals are given in Table 1 . All animals developed large myocardial infarctions, with infarct size ranging from 37% to 55% of the LV circumference. The infarct sizes were similar for all three groups ( Table 1) . The RV and LV weights of placebo-treated infarct rats were markedly increased compared with sham-operated animals as well as compared with enalapril-or losartantreated animals (Fig 1) . Enalapril and losartan had similar effects on arterial blood pressure, cardiac output, and systemic vascular resistance ( (Fig 3) . There was a close relation between LV infarct size and collagen volume fraction (%) in untreated infarct rats (n=8, r=.717, P<.044). Perivascular fibrosis normalized to vessel luminal area was similar in all three infarct groups (Table 3) . Similarly, no significant differences between groups were observed for average vessel lumi-LV-weight nal diameter, medial wall thickness of intramural coronary arteries, and the ratio of medial area corrected by luminal area (Table 3) . Capillary density was significantly reduced in untreated infarct rats compared with sham-operated animals. In the enalapril and losartan groups, the capillary density was increased compared with the untreated infarct group, but its value remained lower than that of the sham group (Fig 4) . Plasma and Tissue ACE Activity Baseline characteristics of these separate groups of animals were similar to those of protocol 1. Although the majority of LV tissue was used for measurement of ACE activity, a crude estimate of infarct size assessed from one transversal slice from the middle part of each LV suggested similar infarct sizes from the three infarct RV-weight (Table 4) . However, the degree of inhibition of tissue ACE activity was different in enalapril-and losartan-treated animals. Whereas enalapril was particularly effective in the kidney, the myocardial ACE activity was more inhibited by losartan. Only enalapril reduced skeletal muscle tissue ACE activity below levels observed in sham-operated rats.
Discussion
The salient finding of the present study is that, compared with ACE inhibition, long-term AT1 receptor blockade is equally effective in preventing ventricular LV-minimal coronary vascular resistance remodeling after myocardial infarction. Three lines of evidence support this conclusion. Both AT1 receptor blockade and ACE inhibition (1) prevented the development of RV hypertrophy and, in part, of LV reactive hypertrophy, (2) restored coronary hemodynamics, and (3) attenuated the development of interstitial fibrosis of the noninfarcted hypertrophied LV. These results are consistent with the hypothesis that angiotensin II and its action via AT1 receptors plays an important role for the development of cardiac hypertrophy, depressed coronary flow reserve, and interstitial fibrosis after myocardial infarction.
Effect of ACE Inhibition and AT1 Receptor Blockade on Cardiac Hypertrophy
For interpretation of the absolute and relative weights of the LV after myocardial infarction, the loss of myocardium related to infarction needs to be considered. It has been shown that myocyte hypertrophy occurs in the noninfarcted LV of the rat. 4 The increased LV studies comparing the effects of captopril and hydralazine in the infarcted rat observed a reduced cardiac weight with captopril, whereas hydralazine tended to increase heart weight.44"45 These findings would support the hypothesis that a direct cardiac effect of ACE inhibitors is involved in the reduction of cardiac hypertrophy. However, nonspecific arterial vasodilators such as hydralazine may not represent ideal afterload-reducing agents. As shown by Tsoporis and Leenen,46 longterm therapy with hydralazine in rats is associated with increased cardiac sympathetic activity. The latter may favor the development of cardiac hypertrophy. Conceivably, afterload reduction may result in reduction of LV hypertrophy only if not associated with activation of cardiac sympathetic activity (or an activated reninangiotensin system).
Effect of ACE Inhibition and AT, Receptor
Blockade on Coronary Hemodynamics The potential effects of ACE inhibition on the coronary circulation has recently gained clinical attention in light of the surprising observation in two multicenter trials in which ACE inhibitors attenuated the incidence of recurrent myocardial infarction, irrespective of the degree of LV dysfunction.9'10 In the present study, we investigated the potential of ACE inhibitors to restore the depressed coronary flow reserve in postmyocardial reactive hypertrophy.3 Since arterial pressure is usually decreased in animals with large infarctions and both losartan and enalapril further reduced blood pressure, minimal coronary vascular resistance was calculated for evaluation of treatment effects on coronary hemodynamics.
The present study shows for the first time that long-term inhibition of the renin-angiotensin system both by ACE inhibition and at the level of the AT1 receptor improved minimal coronary vascular resistance. It is possible that the beneficial effect of ACE inhibition or AT1 receptor blockade on coronary hemodynamics is, in part, due to the reduction of reactive hypertrophy, resulting in an improved myocardial capillary density (capillaries per myocyte volume). However, it appears unlikely that the regression of LV hypertrophy can solely account for the complete restoration of minimal coronary vascular resistance, since LV capillary density and interstitial fibrosis were only partially restored. Moreover, coronary flow is regulated predominantly by coronary resistance vessels ranging in diameter from 80 to 200 gm. Thus, besides restoring myocardial capillary density, the beneficial effects of ACE inhibition on coronary hemodynamics should be related to functional or structural changes of coronary resistance vessels. The present study demonstrates that, in contrast to cardiac hypertrophy associated with hypertension, structural alterations do not occur in this normotensive model of post-myocardial infarction reactive hypertrophy, whereas our previous studies have documented endothelial AT1 receptor blockade was more effective than ACE inhibition in blunting the hypertrophic response in a volumeoverload rat model,62 raising the possibility that angiotensin II generated via an angiotensin II-forming enzyme resistant to ACE inhibition acts as trophic factor.63 Importantly, both the pressure-overload and volume-overload rat models are associated with an activated plasma renin-angiotensin system. In contrast, plasma renin activity is not elevated in the chronic phase of the rat infarct model.7'52'56 Importantly, cardiac ACE activity during chronic AT, receptor blockade was not measured in previous studies42'62 and, therefore, the potential contribution of a negative feedback during AT1 receptor blockade on tissue ACE activity remained unsettled. In light of the present findings and the observations from other experimental models, it appears that the relative contributions of angiotensin II and bradykinin to the antihypertrophic effect of ACE inhibition depends on the degree of activation of the systemic and tissue renin-angiotensin systems as well as the experimental model. Moreover, inhibition of both pathways in vivo, ie, the bradykinin breakdown and the AT1 receptor, may not be additive in their effects during long-term therapy.
In summary, the results of this study indicate that chronic ACE inhibition and AT1 receptor blockade are similarly effective in (1) reducing reactive hypertrophy after myocardial infarction, (2) restoring minimal coronary resistance in postinfarction reactive hypertrophy, and (3) attenuating the development of myocardial interstitial fibrosis in the noninfarcted LV. These results are consistent with the hypothesis that angiotensin II and its action via cardiac AT1 receptors play an important role for the development of reactive hypertrophy, depressed coronary flow reserve, and interstitial fibrosis after myocardial infarction. However, the decrease in vascular and renal tissue ACE activity during long-term AT1 receptor blockade suggests that long-term interference at the level of the AT1 receptor is associated with adjustments of other components of the renin-angiotensin system. Thus, the cardiac effects of AT1 receptor blockade in the rat infarct model may be due to multiple actions and interactions, including blockade of cardiac and peripheral AT1 receptors and feedback or secondary downregulation of tissue ACE activities. Finally, the beneficial effects of inhibiting the generation or action of angiotensin II on coronary hemodynamics in postinfarction reactive hypertrophy may have important clinical implications, given the preventive effect of ACE inhibitors on recurrent infarction in patients after infarction.
